Min-Hwa Lee
About
In The Last Decade
Min-Hwa Lee
30 papers receiving 372 citations
Peers
Comparison fields: 5 of 106
- Pharmaceutical Science 195
- Molecular Biology 92
- Pharmacology 50
- Organic Chemistry 50
- Oncology 49
Countries citing papers authored by Min-Hwa Lee
This map shows the geographic impact of Min-Hwa Lee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Min-Hwa Lee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Min-Hwa Lee more than expected).
Fields of papers citing papers by Min-Hwa Lee
This network shows the impact of papers produced by Min-Hwa Lee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Min-Hwa Lee. The network helps show where Min-Hwa Lee may publish in the future.
Co-authorship network of co-authors of Min-Hwa Lee
This figure shows the co-authorship network connecting the top 25 collaborators of Min-Hwa Lee. A scholar is included among the top collaborators of Min-Hwa Lee based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Min-Hwa Lee. Min-Hwa Lee is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 6 | |
| 3 | 4 | |
| 4 | 27 | |
| 5 | Optimization of CH 3 COONa 3H 2 O-based PCM for Latent Heat Storage System | 2 |
| 6 | 25 | |
| 7 | 33 | |
| 8 | 111 | |
| 9 | Statatistical Analysis of Three Sequence-Three Periods Bioequivalence Study : Application to Bioequivalence Test of Ondansetron Formulations | 0 |
| 10 | Development of $K-BEtest^{\circledR}$, a Computer Program for the Analysis of Bioequivalence | 2 |
| 11 | 24 | |
| 12 | 4 | |
| 13 | 9 | |
| 14 | 8 | |
| 15 | HPLC Determination of Diltiazem and Deacetyldiltiazem in Rat Plasma | 1 |
| 16 | The Effect of Phenobarbital Pretreatment on the Pharmacokinetics of Diltiazem in Rats | 1 |
| 17 | HPLC Assay and Renal Excretion Characteristics of Theophylline and Its Metabolites in Rat | 1 |
| 18 | Preparation of Furosemide Retard Tablets Using Hydroxyethylcellulose as Matrix Forming Material | 0 |
| 19 | Effects of Blended Chinese Traditional Medicine, Ssang Wha Tang, on Hepatic Clearance of Sulfobromophthalein in Rats | 1 |
| 20 | Dissolution Characteristics of Hydrophobic Drug-Soluble Carrier Coprecipitate (I)-Enhanced Dissolution Rates of Furosemide from Furosemide Polymer Coprecipitates- | 3 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.